The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.

An, Gun Hee

The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. [electronic resource] - Journal of immunology research 2014 - 828732 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2314-7156

10.1155/2014/828732 doi


Adult
Antibodies--blood
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Chronic Disease
Disease Progression
Drug Administration Schedule
Drug Therapy, Combination
Female
Glomerular Filtration Rate
Graft Rejection--blood
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunologic Factors--therapeutic use
Kidney Transplantation
Male
Middle Aged
Renal Insufficiency, Chronic--immunology
Rituximab
Treatment Outcome